Showing results (171-180 of 315) with videos related to
Sort By:
Pageof 32
Investigational New Drugs|May 1, 1991
Esorubicin in advanced endometrial cancer: an ineffective and potentially toxic therapy. A Southwest Oncology Group studyJ B Green, S Green, R V O'Toole, et al.Journal of Pharmaceutical Sciences|January 1, 1980
Mass spectrometry of chlorambucil, its degradation products, and its metabolite in biological samplesS Y Chang, B J Larcom, D S Alberts, et al.Steroids|November 30, 1999
A convenient synthesis of dinorbile acids: oxidative hydrolysis of norbile acid nitrilesA K Batta, S C Datta, G S Tint, et al.Cancer Chemotherapy and Pharmacology|January 1, 1981
Pharmacologic studies of anticancer drugs with the human tumor stem cell assayD S Alberts, S E Salmon, H S Chen, et al.Gastroenterology|April 2, 2004
Adenoma characteristics as risk factors for recurrence of advanced adenomasM E Martínez, R Sampliner, J R Marshall, et al.International Journal of Cancer|January 15, 1989
Pharmacokinetics of N-4-hydroxyphenyl-retinamide and the effect of its oral administration on plasma retinol concentrations in cancer patientsY M Peng, W S Dalton, D S Alberts, et al.Cancer Treatment Reports|September 1, 1984
Plasma kinetics of oral retinol in cancer patientsG E Goodman, D S Alberts, Y M Peng, et al.Gynecologic Oncology|December 1, 1994
In vitro drug testing of ovarian cancer using the human tumor colony-forming assay: comparison of in vitro response and clinical outcomeM Federico, D S Alberts, D J Garcia, et al.Cancer|December 1, 1980
Prediction of outcome in metastatic breast cancer treated with adriamycin combination chemotherapyC H Nash, S E Jones, T E Moon, et al.American Journal of Clinical Oncology|February 1, 1992
Evaluation of amonafide in cervical cancer, phase II. A SWOG studyV K Malviya, P Y Liu, D S Alberts, et al.Pageof 32